Center for Comprehensive Genetic Services, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
School of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
BMC Neurol. 2024 Nov 20;24(1):455. doi: 10.1186/s12883-024-03963-y.
Hereditary sensory and autonomic neuropathy type 9 (HSAN9) is a rare genetic disorder caused by genetic alterations in the TECPR2 locus and is characterized by developmental and intellectual disability, respiratory dysfunction, gastroesophageal reflux disease (GERD), and sensory and autonomic dysfunction, which are shared among the HSAN family.
Whole-exome sequencing (WES) was performed on samples from both probands, and the relevant genetic variants were confirmed in their families using Sanger sequencing. Additionally, a comprehensive literature review was conducted on previously reported cases of HSAN9, and the clinical and genetic data were assessed to provide insight into the genetic and clinical characteristics of the disease.
We identified two new cases of HSAN9 with a shared novel variant of TECPR2 (NM_014844.5), c.1568del: p.Ser523PhefsTer12, classified as pathogenic according to ACMG guidelines. The probands showed characteristics of GERD, respiratory dysfunction, gait abnormalities, and developmental and speech delay, and both cases were deceased as a result of severe respiratory infection. The results of the literature review included 34 cases from 9 studies, revealing a wide range of genetic and clinical characteristics.
Our study identified two new cases of HSAN9 with a novel variant in TECPR2, confirmed by WES. The clinical characteristics of the patients as well as the conduction of a comprehensive literature review are crucial in the early diagnosis and management of the disease and establishment of genotype-phenotype correlations.
遗传性感觉运动神经病 9 型(HSAN9)是一种罕见的遗传性疾病,由 TECPR2 基因座的基因突变引起,其特征为发育和智力障碍、呼吸功能障碍、胃食管反流病(GERD)以及感觉和自主神经功能障碍,这些都是 HSAN 家族的共有特征。
对两名先证者的样本进行全外显子组测序(WES),并通过 Sanger 测序在其家族中证实相关的遗传变异。此外,对已报道的 HSAN9 病例进行了全面的文献复习,并评估了临床和遗传数据,以深入了解该疾病的遗传和临床特征。
我们发现了两个具有 TECPR2 (NM_014844.5)共同新变异的 HSAN9 新病例,c.1568del:p.Ser523PhefsTer12,根据 ACMG 指南分类为致病性。先证者表现出 GERD、呼吸功能障碍、步态异常、发育和言语延迟的特征,并且两个病例均因严重的呼吸道感染而死亡。文献复习的结果包括来自 9 项研究的 34 例病例,揭示了广泛的遗传和临床特征。
我们通过 WES 鉴定了两个具有 TECPR2 新变异的 HSAN9 新病例。患者的临床特征以及全面的文献复习对于疾病的早期诊断和管理以及建立基因型-表型相关性至关重要。